SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000143
Filing Date
2021-07-14
Accepted
2021-07-14 08:42:16
Documents
15
Period of Report
2021-07-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210714.htm   iXBRL 8-K 47377
2 EX-5.1 exhibit5opinionjuly2021a.htm EX-5.1 6328
6 GRAPHIC exhibit5opinionjuly2021a001.jpg GRAPHIC 262867
7 GRAPHIC exhibit5opinionjuly2021a002.jpg GRAPHIC 106098
  Complete submission text file 0001485003-21-000143.txt   708664

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210714.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210714_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210714_pre.xml EX-101.PRE 13190
8 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210714_htm.xml XML 11729
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211089325
SIC: 2834 Pharmaceutical Preparations